Latest News Companion animals

22 October 2025

Toward innovative veterinary nanoparticle vaccines

Nanoparticles are significant for veterinary vaccine development because they are safer and more effective than conventional formulations. One promising area of research involves self-assembled protein nanoparticles (SAPNs), which have shown potential for enhancing antigen-presenting cell uptake, B-cell activation, and lymph node trafficking.

Numerous nanovaccines have been utilized in veterinary medicine, including natural self-assembled protein nanoparticles, rationally designed self-assembled protein nanoparticles, animal virus-derived nanoparticles, bacteriophage-derived nanoparticles, and plant-derived nanoparticles, which will be discussed in this review.

SAPN vaccines can produce robust cellular and humoral immune responses and have been shown to protect against various animal infectious diseases. This article attempts to summarize these diverse nanovaccine types and their recent research progress in the field of veterinary medicine. Furthermore, this paper highlights their disadvantages and methods for improving their immunogenicity.

Authors: Meiqi Sun, Aldryan Cristianto Pratama, He Qiu, Zehui Liu, Fang He

Source: https://link.springer.com/

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Drug dose and drug choice: Optimizing medical therapy for veterinary cancer

Innovations in animal health: artificial intelligence-enhanced hematocrit analysis for rapid anemia detection in small ruminants

NC State Student Creates Coloring Book to Help Children Picture Possibilities in Veterinary Medicine

Advancing the 3Rs: innovation, implementation, ethics and society

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Toward innovative veterinary nanoparticle vaccines

Comments

List

Add

Tag

Related Articles

08 August 2025
Optimization and validation of metabolomics methods for feline urine and serum towards application in veterinary medicine

Optimization and validation of metabolomics methods for feline urine and serum towards application in veterinary medicine

22 October 2025
Innovative diagnostic strategies for equine habronemiasis: exploring molecular identification, gene expression, and oxidative stress markers

Innovative diagnostic strategies for equine habronemiasis: exploring molecular identification, gene expression, and oxidative stress markers

20 October 2025
Addressing Infection Risk in Veterinary Practice through the Innovative Application of Interactive 3D Animation Methods

Addressing Infection Risk in Veterinary Practice through the Innovative Application of Interactive 3D Animation Methods

20 October 2025
Evaluation of Cognitive Loads Imposed by Traditional Paper-Based and Innovative Computer-Based Instructional Strategies

Evaluation of Cognitive Loads Imposed by Traditional Paper-Based and Innovative Computer-Based Instructional Strategies

15 October 2025
Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

More news

Studying Dogs with Neurogenerative Diseases: Findings Contribute to Understanding of Human Neuropathy

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

An interprofessional role for veterinary medicine in human health promotion and disease prevention